Analyst Ratings for Eidos Therapeutics (EIDX) [Buys]
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/31/2018 | Roth/MKM | Yasmeen Rahimi | New Coverage | Buy (N/A) |
28.00 (N/A) |
11.81 (122.21) |
934.8% | Details |
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/31/2018 | Roth/MKM | Yasmeen Rahimi | New Coverage | Buy (N/A) |
28.00 (N/A) |
11.81 (122.21) |
934.8% | Details |
